FDA Inspection 971865 — Geisinger Medical Center Blood Bank

Geisinger Medical Center Blood Bank — FEI 2571086

The FDA completed an inspection of Geisinger Medical Center Blood Bank on May 11, 2016 in Danville, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 11, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Danville, PA (United States)